Literature DB >> 25522019

Steric parameters, molecular modeling and hydropathic interaction analysis of the pharmacology of para-substituted methcathinone analogues.

F Sakloth1, R Kolanos, P D Mosier, J S Bonano, M L Banks, J S Partilla, M H Baumann, S S Negus, R A Glennon.   

Abstract

BACKGROUND AND
PURPOSE: There is growing concern over the abuse of certain psychostimulant methcathinone (MCAT) analogues. This study extends an initial quantitative structure-activity relationship (QSAR) investigation that demonstrated important steric considerations of seven 4- (or para-)substituted analogues of MCAT. Specifically, the steric character (Taft's steric ES ) of the 4-position substituent affected in vitro potency to induce monoamine release via dopamine and 5-HT transporters (DAT and SERT) and in vivo modulation of intracranial self-stimulation (ICSS). Here, we have assessed the effects of other steric properties of the 4-position substituents. EXPERIMENTAL APPROACH: Definitive steric parameters that more explicitly focus on the volume, width and length of the MCAT 4-position substituents were assessed. In addition, homology models of human DAT and human SERT based upon the crystallized DrosophilaDAT were constructed and docking studies were performed, followed by hydropathic interaction (HINT) analysis of the docking results. KEY
RESULTS: The potency of seven MCAT analogues at DAT was negatively correlated with the volume and maximal width of their 4-position substituents, whereas potency at SERT increased as substituent volume and length increased. SERT/DAT selectivity, as well as abuse-related drug effects in the ICSS procedure, also correlated with the same parameters. Docking solutions offered a means of visualizing these findings. CONCLUSIONS AND IMPLICATIONS: These results suggest that steric aspects of the 4-position substituents of MCAT analogues are key determinants of their action and selectivity, and that the hydrophobic nature of these substituents is involved in their potency at SERT.
© 2014 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25522019      PMCID: PMC4403088          DOI: 10.1111/bph.13043

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  Hydrophobicity: is LogP(o/w) more than the sum of its parts?

Authors:  G Eugene Kellogg; D J Abraham
Journal:  Eur J Med Chem       Date:  2000 Jul-Aug       Impact factor: 6.514

2.  Clustal W and Clustal X version 2.0.

Authors:  M A Larkin; G Blackshields; N P Brown; R Chenna; P A McGettigan; H McWilliam; F Valentin; I M Wallace; A Wilm; R Lopez; J D Thompson; T J Gibson; D G Higgins
Journal:  Bioinformatics       Date:  2007-09-10       Impact factor: 6.937

3.  Importance of valine at position 152 for the substrate transport and 2beta-carbomethoxy-3beta-(4-fluorophenyl)tropane binding of dopamine transporter.

Authors:  S H Lee; M Y Chang; K H Lee; B S Park; Y S Lee; H R Chin; Y S Lee
Journal:  Mol Pharmacol       Date:  2000-05       Impact factor: 4.436

4.  Inhibition of plasma membrane monoamine transporters by beta-ketoamphetamines.

Authors:  N V Cozzi; M K Sievert; A T Shulgin; P Jacob; A E Ruoho
Journal:  Eur J Pharmacol       Date:  1999-09-17       Impact factor: 4.432

5.  Dopamine transporter: transmembrane phenylalanine mutations can selectively influence dopamine uptake and cocaine analog recognition.

Authors:  Z Lin; W Wang; T Kopajtic; R S Revay; G R Uhl
Journal:  Mol Pharmacol       Date:  1999-08       Impact factor: 4.436

6.  The binding sites for cocaine and dopamine in the dopamine transporter overlap.

Authors:  Thijs Beuming; Julie Kniazeff; Marianne L Bergmann; Lei Shi; Luis Gracia; Klaudia Raniszewska; Amy Hauck Newman; Jonathan A Javitch; Harel Weinstein; Ulrik Gether; Claus J Loland
Journal:  Nat Neurosci       Date:  2008-06-22       Impact factor: 24.884

7.  How dopamine transporter interacts with dopamine: insights from molecular modeling and simulation.

Authors:  Xiaoqin Huang; Chang-Guo Zhan
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

8.  Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation.

Authors:  Leyla Celik; Steffen Sinning; Kasper Severinsen; Carsten G Hansen; Maria S Møller; Mikael Bols; Ove Wiborg; Birgit Schiøtt
Journal:  J Am Chem Soc       Date:  2008-03-04       Impact factor: 15.419

9.  Methcathinone: a new and potent amphetamine-like agent.

Authors:  R A Glennon; M Yousif; N Naiman; P Kalix
Journal:  Pharmacol Biochem Behav       Date:  1987-03       Impact factor: 3.533

10.  Dopamine transporter comparative molecular modeling and binding site prediction using the LeuT(Aa) leucine transporter as a template.

Authors:  Martín Indarte; Jeffry D Madura; Christopher K Surratt
Journal:  Proteins       Date:  2008-02-15
View more
  22 in total

1.  Structure-activity relationships of bath salt components: substituted cathinones and benzofurans at biogenic amine transporters.

Authors:  Amy J Eshleman; Shanthi Nagarajan; Katherine M Wolfrum; John F Reed; Tracy L Swanson; Aaron Nilsen; Aaron Janowsky
Journal:  Psychopharmacology (Berl)       Date:  2018-11-05       Impact factor: 4.530

2.  Cocaine-like discriminative stimulus effects of amphetamine, cathinone, methamphetamine, and their 3,4-methylenedioxy analogs in male rhesus monkeys.

Authors:  Douglas A Smith; Bruce E Blough; Matthew L Banks
Journal:  Psychopharmacology (Berl)       Date:  2016-10-05       Impact factor: 4.530

Review 3.  Using Ca2+-channel biosensors to profile amphetamines and cathinones at monoamine transporters: electro-engineering cells to detect potential new psychoactive substances.

Authors:  Tyler W E Steele; Jose M Eltit
Journal:  Psychopharmacology (Berl)       Date:  2018-11-17       Impact factor: 4.530

4.  The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.

Authors:  Richard A Glennon
Journal:  J Med Chem       Date:  2017-03-15       Impact factor: 7.446

Review 5.  Neurotoxicology of Synthetic Cathinone Analogs.

Authors:  Mariana Angoa-Pérez; John H Anneken; Donald M Kuhn
Journal:  Curr Top Behav Neurosci       Date:  2017

6.  Decoding the Structure of Abuse Potential for New Psychoactive Substances: Structure-Activity Relationships for Abuse-Related Effects of 4-Substituted Methcathinone Analogs.

Authors:  S Stevens Negus; Matthew L Banks
Journal:  Curr Top Behav Neurosci       Date:  2017

7.  Systematic Structure-Activity Studies on Selected 2-, 3-, and 4-Monosubstituted Synthetic Methcathinone Analogs as Monoamine Transporter Releasing Agents.

Authors:  Donna Walther; Abdelrahman R Shalabi; Michael H Baumann; Richard A Glennon
Journal:  ACS Chem Neurosci       Date:  2018-11-07       Impact factor: 4.418

8.  Synthetic Cathinones: A Brief Overview of Overviews with Applications to the Forensic Sciences.

Authors:  Richard A Glennon; Małgorzata Dukat
Journal:  Ann Forensic Res Anal       Date:  2017-03-21

9.  Abuse-related neurochemical and behavioral effects of cathinone and 4-methylcathinone stereoisomers in rats.

Authors:  Blake A Hutsell; Michael H Baumann; John S Partilla; Matthew L Banks; Rakesh Vekariya; Richard A Glennon; S Stevens Negus
Journal:  Eur Neuropsychopharmacol       Date:  2015-12-11       Impact factor: 4.600

10.  Cocaine-like discriminative stimulus effects of alpha-pyrrolidinovalerophenone, methcathinone and their 3,4-methylenedioxy or 4-methyl analogs in rhesus monkeys.

Authors:  Douglas A Smith; S Stevens Negus; Justin L Poklis; Bruce E Blough; Matthew L Banks
Journal:  Addict Biol       Date:  2016-04-06       Impact factor: 4.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.